ADMA Biologics Inc (ADMA)

Name: ADMA Biologics Inc (ADMA) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: ADMA Biologics Inc (ADMA)

Stock Card

$9.62

$0.04 (0.42%)

As on 04-Sep-2026 16:00EDT

Market cap

$2,146 Mln

Revenue (TTM)

$512 Mln

P/E Ratio

13.7

P/B Ratio

5.3

Div. Yield

0 %

ADMA Biologics (ADMA) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 9.39 High: 9.62

52 Week Range

Low: 7.21 High: 20.46

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

0.4 %
ROCE

-- %
Industry P/E

37.91
EV/EBITDA

9.5
Debt to Equity

0.5
Book Value

$1.8
EPS

$0.7
Face value

--
Shares outstanding

223,984,680

10 Years Aggregate

CFO

$-489.62 Mln

EBITDA

$-313.04 Mln

Net Profit

$-506.33 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
ADMA Biologics (ADMA)	-47.3	10.1	24.0	-43.1	35.2	48.5	5.2
BSE Sensex^*	-10.1	-3.6	2.5	-5.7	4.9	5.5	10.1
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 04-Sep-2026 | *As on 07-Sep-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
ADMA Biologics (ADMA)	6.4	275.3	16.5	175.2	-27.7	-51.3	67.4
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
ADMA Biologics (ADMA)	9.6	2,145.8	512.3	169.0	44.0	38.2	13.7	5.3
Amneal Pharmaceuticals Inc Class A (AMRX)	17.4	6,074.3	3,117.6	157.4	14.7	--	36.3	188.5
Axsome Therapeutics (AXSM)	206.7	10,826.1	776.6	-191.6	-17.6	-223.4	--	131.0
BridgeBio Pharma (BBIO)	74.8	14,630.7	691.8	-696.2	-89.1	--	--	123.7
Corcept Therapeutics (CORT)	111.6	12,065.9	830.8	54.9	3.2	8.1	248	17.3
Dr. Reddy's Laboratories - ADR	12.0	10,020.9	332,834.2	33,166.6	11.1	8.9	29.3	2.5
Elanco Animal Health (ELAN)	24.5	12,236.5	5,020.0	-199.0	1.6	-3	--	1.9
Ligand Pharmaceuticals (LGND)	285.6	5,693.6	290.5	197.2	82.5	19.9	29.8	5.9
Liquidia Technologies Inc (LQDA)	68.7	6,145.7	450.9	138.6	39.1	115.6	49	30.7
Twist Bioscience Corp (TWST)	124.7	8,210.6	431.8	-136.7	-30.8	-30.3	--	19.0

Shareholding Pattern

View Details

About ADMA Biologics (ADMA)

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates... through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey. Read more

Co-Founder, President, CEO & Director

Mr. Adam S. Grossman
Co-Founder, President, CEO & Director

Mr. Adam S. Grossman
Headquarters

Ramsey, NJ
Website

https://www.admabiologics.com

FAQs for ADMA Biologics (ADMA)

What is the current share price of ADMA Biologics Inc (ADMA) Today?

The share price of ADMA Biologics Inc (ADMA) is $9.62 (NASDAQ) as of 04-Sep-2026 16:00 EDT. ADMA Biologics Inc (ADMA) has given a return of 35.23% in the last 3 years.

What is the current PB & PE ratio of ADMA Biologics Inc (ADMA)?

The P/E ratio of ADMA Biologics Inc (ADMA) is 13.69 times as on 04-Sep-2026, a 64 discount to its peers’ median range of 37.91 times.
The P/B ratio of ADMA Biologics Inc (ADMA) is 5.26 times as on 04-Sep-2026, a 32 discount to its peers’ median range of 7.69 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	30.27	9.32
2024	21.33	12.08
2023	-36.17	7.55
2022	-11.94	5.18
2021	-3.56	1.81

What is the 52 Week High and Low of ADMA Biologics Inc (ADMA)?

The 52-week high and low of ADMA Biologics Inc (ADMA) are Rs 20.46 and Rs 7.21 as of 07-Sep-2026.

What is the market cap of ADMA Biologics Inc (ADMA)?

ADMA Biologics Inc (ADMA) has a market capitalisation of $ 2,146 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in ADMA Biologics Inc (ADMA)?

Before investing in ADMA Biologics Inc (ADMA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.